FDAFDA · Food and drugs·Recall number D-0299-2022
Veklury (remdesivir) for injection, 100 mg/vial, Single-Dose Vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA 94404, NDC 61958-2901-2
Published January 5, 2022 · Recall initiated: December 3, 2021
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Particulate Matter: investigation into a customer complaint confirmed the presence of glass particulates.
What to do
Voluntary: Firm initiated · Press Release
Recall details
- Brand
- VEKLURY
- Manufacturer
- Gilead Sciences, Inc.
- Distributor
- Nationwide in the USA
- Lot
- Lots: 2141001-1A, 2141002-1A, Exp. 01/2024
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.